Reality check for cardiac troponin testing – Sometimes the result is wrong

Clinical Biochemistry

Volumn 49, Issue 15, 2016, Pages 1107-1108

  Kavsak, Peter A ^a   Saenger, Amy K ^b   Hickman, Peter E ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Analytical errors; Cardiac troponin; Guidelines; Interferences; Laboratory testing; Variation

Indexed keywords

ALKALINE PHOSPHATASE; EDETIC ACID; LITHIUM; TROPONIN; TROPONIN I; TROPONIN T;

CARDIOVASCULAR DISEASE ASSESSMENT; EDITORIAL; HEART INFARCTION; HEMOLYSIS; HUMAN; IMMUNOASSAY; LABORATORY PERSONNEL; LABORATORY TEST; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; THORAX PAIN; BLOOD; DIAGNOSTIC ERROR; STANDARDS;

DIAGNOSTIC ERRORS; HUMANS; TROPONIN I; TROPONIN T;

EID: 84991744715     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.09.007     Document Type: Editorial

References (20)

1. [1] Kavsak, P.A., Lai, L., Langman, L., Jones, P.M., Hammett-Stabler, C.A., Clinical Biochemistry 2015 year in review: material not for the faint of heart. Clin. Biochem. 48 (2015), 1211–1212.
2. [2] Apple, F.S., Jaffe, A.S., Collinson, P., Mockel, M., Ordonez-Llanos, J., Lindahl, B., et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin. Biochem. 48 (2015), 201–203.
3. [3] Roffi, M., Patrono, C., Collet, J.P., Mueller, C., Valgimigli, M., Andreotti, F., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37 (2016), 267–315.
4. [4] Kavsak, P.A., Jaffe, A.S., Hickman, P.E., Mills, N.L., Humphries, K.H., McRae, A., et al. Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. Clin. Biochem. 47 (2014), 155–157.
5. [5] Pickering, J.W., Greenslade, J.H., Cullen, L., Flaws, D., Parsonage, W., George, P., et al. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart 102 (2016), 1270–1278.
6. [6] Chenevier-Gobeaux, C., Meune, C., Lefevre, G., Doumenc, B., Sorbets, E., Peschanski, N., Ray, P., A single value of high-sensitive troponin T below the limit of detection is not enough for ruling out non ST elevation myocardial infarction in the emergency department. Clin. Biochem. 49:15 (2016), 1113–1117.
7. [7] Herman, D.S., Ranjitkar, P., Yamaguchi, D., Grenache, D.G., Greene, D.N., Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification. Clin. Biochem. 49:15 (2016), 1118–1121.
8. [8] Hickman, P.E., Miller, E., Koerbin, G., Potter, J.M., Changes in troponin kits preclude meaningful collection of data on population 99th percentiles. Ann. Clin. Biochem. 41 (2004), 503–504.
9. [9] Kavsak, P.A., Hill, S.A., McQueen, M.J., Devereaux, P.J., Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin. Chem. 59 (2013), 574–576.
10. [10] Saenger, A.K., Beyrau, R., Braun, S., Cooray, R., Dolci, A., Freidank, H., et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412 (2011), 748–754.
11. [11] Kavsak, P.A., Don-Wauchope, A.C., Hill, S.A., Worster, A., Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms. Clin. Chem. 62 (2016), 887–889.
12. [12] Kavsak, P.A., Beattie, J., Pickersgill, R., Ford, L., Caruso, N., Clark, L., A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city. Pract. Lab. Med. 1 (2015), 28–34.
13. [13] Lyon, M.E., Ball, C.L., Krause, R.D., Slotsve, G.A., Lyon, A.W., Effect of hemolysis on cardiac troponin T determination by the Elecsys 2010 immunoanalyzer. Clin. Biochem. 37:8 (Aug 2004), 698–701.
14. [14] Bais, R., The effect of sample hemolysis on cardiac troponin I and T assays. Clin. Chem. 56:8 (Aug 2010), 1357–1359.
15. [15] Kock, C.D., Wockenfus, A.M., Saenger, A.K., Jaffe, A.S., Karon, B., BD rapid serum tubes reduce false positives plasma troponin T results on the Roche Cobas e411 analyzer. Clin. Biochem., 2012, 842–844.
16. [16] Kavsak, P.A., Worster, A., Dichotomizing high-sensitivity cardiac troponin T results and important analytical considerations. J. Am. Coll. Cardiol., 59, 2012, 157.
17. [17] Simons, J., Beach, L., Clark, L., Kavsak, P.A., Matrix and bilirubin interference for high-sensitivity cardiac troponin I. Clin. Chim. Acta 442 (2015), 49–51.
18. [18] Kavsak, P.A., Caruso, N., Beattie, J., Clark, L., Centrifugation—an important pre-analytical factor for the Abbott Architect high-sensitivity cardiac troponin I assay. Clin. Chim. Acta 436 (2014), 273–275.
19. [19] Puelacher, C., Twerenbold, R., Mosimann, T., Boeddinghaus, J., Rubini Gimenez, M., Wildi, K., et al. Effects of hemolysis on the diagnostic accuracy of cardiac troponin I for the diagnosis of myocardial infarction. Int. J. Cardiol. 187 (2015), 313–315.
20. [20] Jaffe, A.S., Vasile, V.C., Milone, M., Saenger, A.K., Olson, K.N., Apple, F.S., Disease skeletal muscle a noncardiac source of increased circulating concentrations of cardiac troponin T. J. Am. Coll. Cardiol. 58 (2011), 1819–1824.